NYSE US 100

NYSE US 100 handeln
18.507,24 PKT -52,91 PKT -0,29 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Analysen zu NYSE US 100-Werten

Datum Rating Analyst
05.11.12 Bayer buy Citigroup Corp.
05.11.12 Boeing buy Deutsche Bank Securities
02.11.12 Bayer neutral Exane-BNP Paribas SA
02.11.12 Bayer neutral Nomura
02.11.12 Exelon sell UBS AG
02.11.12 Texas Instruments sector perform RBC Capital Markets
02.11.12 Pfizer buy UBS AG
02.11.12 ExxonMobil kaufen National-Bank AG
02.11.12 ExxonMobil halten Independent Research GmbH
02.11.12 Pfizer neutral Sarasin Research
02.11.12 UnitedHealth kaufen Fuchsbriefe
02.11.12 ExxonMobil neutral Sarasin Research
01.11.12 Allstate neutral UBS AG
01.11.12 Allstate buy Sarasin Research
31.10.12 Bayer halten National-Bank AG
31.10.12 Bayer verkaufen Norddeutsche Landesbank (Nord/LB)
31.10.12 Bayer buy Deutsche Bank AG
31.10.12 Bayer hold Société Générale Group S.A. (SG)
31.10.12 Walmart buy Jefferies & Company Inc.
30.10.12 Bayer buy Commerzbank Corp. & Markets
30.10.12 Bayer halten Independent Research GmbH
30.10.12 Procter Gamble halten Independent Research GmbH
30.10.12 Bayer verkaufen Hamburger Sparkasse AG (Haspa)
30.10.12 Bayer buy Sarasin Research
30.10.12 JPMorgan Chase outperform Raymond James Financial, Inc.
30.10.12 Procter Gamble outperform Sanford C. Bernstein and Co., Inc.
29.10.12 HP sell UBS AG
29.10.12 Merck buy UBS AG
29.10.12 Coca-Cola neutral Nomura
29.10.12 Lockheed Martin neutral J.P. Morgan Cazenove
29.10.12 Colgate-Palmolive sector perform RBC Capital Markets
29.10.12 Procter Gamble sector perform RBC Capital Markets
29.10.12 Coca-Cola hold Société Générale Group S.A. (SG)
26.10.12 McDonalds neutral Sarasin Research
26.10.12 CME Group A buy UBS AG
26.10.12 McDonalds buy UBS AG
26.10.12 AT&T sector perform Scotia Capital Markets
26.10.12 Procter Gamble equal-weight Morgan Stanley
26.10.12 Boeing outperform RBC Capital Markets
26.10.12 Procter Gamble neutral Sarasin Research